| |
|
Department of Urology Home
Contact Us
About Us
Patient Care
Services
Appointments
Faculty and Staff
Patient and Visitor Information
Hospital Directions
Educational Materials
Education
Residency Program
Current Residents
UI Graduate Medical Education
Urology Electronic Resource Center
Clinical Trials
Research
J. Hayden Fry Center for Prostate Cancer Research
Bladder Cancer Research
David M. Lubaroff Laboratory
Providers
Referring Physician Resources
Flocks Urological Society
News and Events
|
|
|
Yi Luo, MD, PhD
Assistant Professor
Urologic Oncology Research
Education
- 1978Nanjing Medical University, China, MD
- 1982Nanjing Medical University, China, MS
- 1994University of New Brunswick, Canada, PhD
Postgraduate Training
- 1987-89Research Fellow, Department of Molecular Immunology. Roswell Park Cancer Institute, Buffalo
- 1994-96Postdoctoral Fellow, Division of Urology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston
Academic Positions
- 1983-86Lecturer, Biochemistry, Nanjing Medical University, China
- 1996-2000Instructor, Surgery, Division of Urology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston
- 2000-02Associate Research Scientist, University of Iowa Department of Urology
- 2002-04Faculty Associate, University of Iowa Department of Urology
- 2004Assistant Professor, University of Iowa Department of Urology
Affiliations
- 1998American Association for Cancer Research
- 2000American Association for The Advancement of Science
- 2003Society for Basic Urologic Research
- 2004University of Iowa Holden Comprehensive Cancer Center
Honors
- 1989-93Graduate Fellowship Award, University of New Brunswick, Canada
- 1996-98American Foundation for Urologic Disease PhD Research Scholar
- 2001-03Pharmacia 2001 Ellence Research Fund
- 2001-02American Cancer Society Seed Grant
- 2003American Urological Association Traveling Fellowship Award
Research Interests
- Bladder cancer immunotherapy
- Bladder immunogenic/autoimmune disorders
- Peptide-based targeting therapy
- Recombinant BCG development
- Urothelium-specific transgenic modeling
|
|
|